TR201100153A2 - Efervesan bifosfonat formülasyonları. - Google Patents

Efervesan bifosfonat formülasyonları.

Info

Publication number
TR201100153A2
TR201100153A2 TR2011/00153A TR201100153A TR201100153A2 TR 201100153 A2 TR201100153 A2 TR 201100153A2 TR 2011/00153 A TR2011/00153 A TR 2011/00153A TR 201100153 A TR201100153 A TR 201100153A TR 201100153 A2 TR201100153 A2 TR 201100153A2
Authority
TR
Turkey
Prior art keywords
bisphosphonate formulations
effervescent
formulations
effervescent bisphosphonate
pharynx
Prior art date
Application number
TR2011/00153A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/00153A priority Critical patent/TR201100153A2/tr
Priority to PCT/TR2012/000005 priority patent/WO2012093974A1/en
Priority to EP12706949.0A priority patent/EP2661262B1/en
Priority to TR2012/00214A priority patent/TR201200214A2/tr
Priority to TR2012/00216A priority patent/TR201200216A2/tr
Priority to TR2012/00215A priority patent/TR201200215A2/tr
Priority to EP12706345.1A priority patent/EP2661257B1/en
Priority to PCT/TR2012/000009 priority patent/WO2012093978A1/en
Publication of TR201100153A2 publication Critical patent/TR201100153A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılmak üzere alendronat ve/veya farmasötik açıdan uygun herhangi bir türevini içeren ağız, bukkal kavite, farinks, larinks ve özafagusun epiteliyal ve mukozal tabakasını erezyon, ülser ve benzeri irritasyonlardan komyan, biyoyararlanımı yüksek efervesan formdaki formülasyonlara ilişkindir.
TR2011/00153A 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları. TR201100153A2 (tr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
PCT/TR2012/000005 WO2012093974A1 (en) 2011-01-06 2012-01-06 Improved bisphosphonate formulations
EP12706949.0A EP2661262B1 (en) 2011-01-06 2012-01-06 Improved bisphosphonate formulations
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
EP12706345.1A EP2661257B1 (en) 2011-01-06 2012-01-06 Effervescent bisphosphonate formulations
PCT/TR2012/000009 WO2012093978A1 (en) 2011-01-06 2012-01-06 Effervescent bisphosphonate formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.

Publications (1)

Publication Number Publication Date
TR201100153A2 true TR201100153A2 (tr) 2012-07-23

Family

ID=45771873

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2011/00153A TR201100153A2 (tr) 2011-01-06 2011-01-06 Efervesan bifosfonat formülasyonları.
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.

Family Applications After (3)

Application Number Title Priority Date Filing Date
TR2012/00216A TR201200216A2 (tr) 2011-01-06 2012-01-06 Kombine tedavi paketi.
TR2012/00215A TR201200215A2 (tr) 2011-01-06 2012-01-06 Geliştirilmiş farmasötik formülasyonlar.
TR2012/00214A TR201200214A2 (tr) 2011-01-06 2012-01-06 Alendronat içeren farmasötik granüller.

Country Status (3)

Country Link
EP (1) EP2661257B1 (tr)
TR (4) TR201100153A2 (tr)
WO (1) WO2012093978A1 (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196315B (it) 1984-10-29 1988-11-16 Gentili Ist Spa Procedimento per la preparazione di acidi difosfonici
TR200900880A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.

Also Published As

Publication number Publication date
EP2661257B1 (en) 2017-11-15
TR201200214A2 (tr) 2012-07-23
TR201200216A2 (tr) 2012-07-23
TR201200215A2 (tr) 2012-07-23
WO2012093978A1 (en) 2012-07-12
EP2661257A1 (en) 2013-11-13

Similar Documents

Publication Publication Date Title
CY1124219T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τοπικο αναiσθητiκο οπως η βουπιβακαϊνη για τοπικη χορηγηση στο στομα ή τον φαρυγγα
CY1117757T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
TWI369982B (en) Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
EA201391087A1 (ru) Оральные лекарственные формы препарата тазоцитиниба с модифицированным высвобождением
UY32487A (es) Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona
HK1257400A1 (zh) 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物
HN2012000023A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
ZA201205441B (en) Dental strip for administration of oral treatment
MX337849B (es) Composiciones y metodos para inhibicion de la via jak.
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
PL2281528T3 (pl) Układ do leczenia próchnicy zębów laserem
PL2293805T3 (pl) Kompozycja do ssania, do leczenia chorób zapalnych jamy ustnej i gardłowej
CY1117795T1 (el) Φαρμακευτικες συνθεσεις απαλλαγμενες κιτρικου αλατος οι οποιες περιεχουν ανακινρα
IL208848A0 (en) Compositions for the treatment and prevention of infections of the oral cavity
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
TR201100153A2 (tr) Efervesan bifosfonat formülasyonları.
TR201100149A2 (tr) Geliştirilmiş risedronat formülasyonu.
ATE477820T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
UA44673U (ru) Способ лечения воспалительных заболеваний пародонта и слизистой оболочки полости рта
EA200801003A1 (ru) Фармацевтически приемлемые соли и гидраты ризедроновой кислоты
ATE471318T1 (de) Neue indol-pyrrol-derivate zur behandlung proliferativer und inflammatorischer krankheiten
TR201100151A2 (tr) İbandronate formülasyonu.
CY1118255T1 (el) Υποκατεστημενα 6-αμινο-νικοτιναμιδια τα οποια φερουν μια ομαδα που περιεχει οη ως διαμορφωτες των kcnq2/3
EP2767286A4 (de) Orale pharmazeutische zusammensetzung zur behandlung von entzündlichen magen-darm-erkrankungen